Clinical Trial: Adapting the Fear of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06872840) titled 'Adapting the Fear of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility' on March 01.

Brief Summary: Clinical levels of fear of cancer recurrence (FCR) affect up to 59% of adult cancer survivors. Family caregivers experience equal or greater levels of FCR, which has been linked to lower quality of life and increased distress. FCR can be addressed in cancer survivors with brief interventions. However, none of these interventions have been tested with parents of childhood cancer survivors. This is an urgent gap: the survival rates of childhood cancer have increased more rapidly than for adult cancers...